Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10223645 | 0.94 | KCNH2 (0.75) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL16188305 | 0.91 | KCNH2 (0.72) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL18379298 | 0.91 | KCNH2 (0.72) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL20952515 | 0.91 | KCNH2 (0.72) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL10222773 | 0.91 | KCNH2 (0.71) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL894497 | 0.90 | KCNH2 (0.49) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL16309220 | 0.90 | KCNH2 (0.58) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL20952287 | 0.89 | KCNH2 (0.56) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL16291016 | 0.89 | KCNH2 (0.56) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 | |
| SCHEMBL16291015 | 0.89 | KCNH2 (0.56) | KCNH2CYP2C9CYP2C19CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120083483-A1 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | MERCK SHARP & DOHME CORP (NJ) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083483-A1 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | HAVCR2, HCCS, EIF2AK2 | KCNH2 4621/4885CYP2C9 2551/4885CYP2C19 3129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.